Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted therapies in severe asthma: the discovery of new molecules].

Revue des maladies respiratoires - 1 Oct 2013

Charriot J, Gamez A-S, Humbert M, Chanez P, Bourdin A

Abstract excerpt

The pathophysiological mechanisms involved in the chronicity and phenotypic heterogeneity of asthma offer the prospect of new therapeutic opportunities. A better clinical and biological characterisation of selected patients has led to the development of targeted therapies. Studies are under way to demonstrate their efficacy and tolerance and also their impact on the natural history of the disease. This revue aims...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Severity of Illness Index
Share to Asthma
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drugs, Investigational

Share to TSLP gene

Share to Molecular Targeted Therapy

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 24182649
DOI: 10.1016/j.rmr.2013.02.018

Genes

TNF
TSLP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted therapies in severe asthma: the discovery of new molecules].PMID 24182649Read ↗

Immunologic therapeutic interventions in asthma: impact on natural history.Semantic proximity Read ↗

Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Semantic proximity Read ↗

What goes up must come down: biomarkers and novel biologicals in severe asthma.Semantic proximity Read ↗

Biologics in severe asthma: the overlap endotype - opportunities and challenges.Semantic proximity Read ↗

Future treatment for asthma.Semantic proximity Read ↗

Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals.Semantic proximity Read ↗

The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.Semantic proximity Read ↗

Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.Semantic proximity Read ↗

Biologic Therapy and Novel Molecular Targets of Severe Asthma.Semantic proximity Read ↗

Anti-interleukin-5 therapy in severe asthma.Semantic proximity Read ↗

[Immunogene therapy against allergic asthma].Semantic proximity Read ↗

Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.